182 related articles for article (PubMed ID: 28823571)
1. Histopathological evidence of neoplastic progression of von Meyenburg complex to intrahepatic cholangiocarcinoma.
Bhalla A; Mann SA; Chen S; Cummings OW; Lin J
Hum Pathol; 2017 Sep; 67():217-224. PubMed ID: 28823571
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocarcinoma arising in von Meyenburg complexes: report of four cases.
Song JS; Lee YJ; Kim KW; Huh J; Jang SJ; Yu E
Pathol Int; 2008 Aug; 58(8):503-12. PubMed ID: 18705771
[TBL] [Abstract][Full Text] [Related]
3. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma.
Nakanuma Y; Uchida T; Sato Y; Uesaka K
Hum Pathol; 2017 Feb; 60():46-57. PubMed ID: 27984121
[TBL] [Abstract][Full Text] [Related]
4. Hilar bile duct cancer associated with preoperatively undetectable von Meyenburg complex--report of a case.
Eguchi S; Tajima Y; Yanaga K; Okudaira S; Furui J; Hayashi T; Kanematsu T
Hepatogastroenterology; 2004; 51(59):1301-3. PubMed ID: 15362738
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
6. Proliferative index facilitates distinction between benign biliary lesions and intrahepatic cholangiocarcinoma.
Tsokos CG; Krings G; Yilmaz F; Ferrell LD; Gill RM
Hum Pathol; 2016 Nov; 57():61-67. PubMed ID: 27396933
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature.
Xu AM; Xian ZH; Zhang SH; Chen XF
Eur J Gastroenterol Hepatol; 2009 May; 21(5):580-4. PubMed ID: 19282767
[TBL] [Abstract][Full Text] [Related]
8. EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.
Tanaka M; Shibahara J; Ishikawa S; Ushiku T; Morikawa T; Shinozaki-Ushiku A; Hayashi A; Misumi K; Tanaka A; Katoh H; Sakuma K; Kokudo T; Inagaki Y; Arita J; Sakamoto Y; Hasegawa K; Fukayama M
Virchows Arch; 2019 Jan; 474(1):39-46. PubMed ID: 30349952
[TBL] [Abstract][Full Text] [Related]
9. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma.
Shimonishi T; Miyazaki K; Kono N; Sabit H; Tuneyama K; Harada K; Hirabayashi J; Kasai K; Nakanuma Y
Hum Pathol; 2001 Mar; 32(3):302-10. PubMed ID: 11274640
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
[TBL] [Abstract][Full Text] [Related]
12. Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
Schlitter AM; Born D; Bettstetter M; Specht K; Kim-Fuchs C; Riener MO; Jeliazkova P; Sipos B; Siveke JT; Terris B; Zen Y; Schuster T; Höfler H; Perren A; Klöppel G; Esposito I
Mod Pathol; 2014 Jan; 27(1):73-86. PubMed ID: 23828315
[TBL] [Abstract][Full Text] [Related]
13. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma.
Sarcognato S; Gringeri E; Fassan M; Di Giunta M; Maffeis V; Guzzardo V; Cillo U; Guido M
Virchows Arch; 2019 Jan; 474(1):29-37. PubMed ID: 30377796
[TBL] [Abstract][Full Text] [Related]
15. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
[TBL] [Abstract][Full Text] [Related]
16. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver.
Shimonishi T; Zen Y; Chen TC; Chen MF; Jan YY; Yeh TS; Nimura Y; Nakanuma Y
Hum Pathol; 2002 May; 33(5):503-11. PubMed ID: 12094375
[TBL] [Abstract][Full Text] [Related]
17. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic Study of Biliary Intraepithelial Neoplasia in Cholangiocarcinoma.
Kim HJ; Kim JS; Kim BH; Bak YT
Dig Surg; 2018; 35(2):116-120. PubMed ID: 28490009
[TBL] [Abstract][Full Text] [Related]
19. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
20. A case of biliary adenofibroma with malignant transformation.
Thai E; Dalla Valle R; Evaristi F; Silini EM
Pathol Res Pract; 2016 May; 212(5):468-70. PubMed ID: 26778388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
